Kane Biotech Inc., a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce it has appointed Pacific Veterinary Sales of Abbotsford, B.C. as a distribution partner for the upcoming StrixNB pet oral care product launch in Western Canada. On January 31, 2013 the company launched a marketing field test for StrixNB in Manitoba through veterinary clinics. The response in Manitoba has been exceptional with over 84% of the veterinary clinics signing up for the Company’s promotional campaign and 61% of these clinics placing orders to regularly carry StrixNB in their clinics.
“Preparations for the launch into Western Canada are well underway and appointing distribution is an important step for this market of over 1200 veterinary clinics” stated Gord Froehlich, President and CEO of Kane Biotech. “Since announcing the market field test in Manitoba our team has been working diligently to prepare for this commercial introduction and have put key systems in place to meet the growing demand for StrixNB”.
Pacific Veterinary Sales has a direct relationship with veterinarians through an established and dedicated sales team that focuses on veterinarians in Western Canada and will warehouse, distribute and sell StrixNB to the veterinary market.
“We are delighted to be working with Kane Biotech to launch their revolutionary new pet oral care product in Western Canada. Our committed core values of customer care specializing in sales and service of veterinary products, a great office team, and 60 dedicated staff are all excited to be part of the StrixNB launch” stated Ken Kasdorf, Director of Sales and Marketing. “We actively attend, sponsor and participate in veterinary conferences, trade shows and industry events and are eager to introduce StrixNB to all clinics from large clinic groups, dental specialists to smaller independent clinics.”
About Pacific Veterinary Sales
Pacific Veterinary Sales is a privately held company established in 1981 and is an established and source of quality products in the veterinary distribution market for Western Canada. They have experienced strong growth over the last twenty years and have an established sales force that focuses on veterinarians in the three western provinces. They have Veterinary sales representatives on the road meeting with veterinarians, technicians and support staff in clinics/hospitals and built great relationships with these accounts.
About Kane Biotech Inc.
Kane Biotech is a biotechnology company engaged in the development and commercialization of products that prevent and remove biofilms. Biofilms develop when bacteria and other microorganisms form a protective matrix that acts as a shield against attack. When in a biofilm, bacteria become highly resistant to antibiotics, biocides, disinfectants, high temperatures and host immune responses. This resiliency contributes to human health problems such as recurrent urinary tract infections, medical device associated infections and tooth decay.
Kane Biotech uses patent protected technologies based on molecular mechanisms of biofilm formation/dispersal and methods for finding compounds that inhibit or disrupt biofilms. The Company has evidence that these technologies have potential to significantly improve the ability to prevent and/or destroy biofilms in several medical and industrial applications.